| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tvardi Therapeutics, Inc. (TVRD) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. TVRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 47.5K | $198.6K | - | |
| Other | 17.5K | $73.2K | - | |
| CFO | 17.5K | $73.2K | - | |
| Other | 4.0K | $16.7K | - | |
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2019 | Menzaghi Frederique Ph.d.85 | Chief Scientific Off,Svp-r&D | Sell | 4,000 | $19.91 | $79,640.00 | -5.9% | |
| Oct 18, 2019 | Menzaghi Frederique Ph.d.85 | Chief Scientific Off,Svp-r&D | Sell | 4,000 | $19.33 | $77,320.00 | -5.6% | |
| Oct 11, 2019 | Menzaghi Frederique Ph.d.85 | Chief Scientific Off,Svp-r&D | Sell | 4,000 | $18.70 | $74,800.00 | -5.3% | |
| Oct 4, 2019 | Menzaghi Frederique Ph.d.85 | Chief Scientific Off,Svp-r&D | Sell | 4,000 | $19.19 | $76,760.00 | -5.0% | |
| Oct 1, 2019 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $18.21 | $45,525.00 | -29.4% | |
| Oct 1, 2019 | Chalmers Derek T | President &CEO | Sell | 10,000 | $18.28 | $182,800.00 | -1.1% | |
| Sep 3, 2019 | Chalmers Derek T | President &CEO | Sell | 5,000 | $23.26 | $116,300.00 | -0.5% | |
| Sep 3, 2019 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $23.31 | $58,275.00 | -29.4% | |
| Sep 3, 2019 | Menzaghi Frederique Ph.d.85 | Chief Scientific Off,Svp-r&D | Sell | 20,000 | $22.92 | $458,400.00 | -20.0% | |
| Aug 1, 2019 | Menzaghi Frederique Ph.d.85 | Chief Scientific Off,Svp-r&D | Sell | 20,000 | $23.24 | $464,800.00 | -16.7% |